The association between alcohol use and cardiovascular disease among people living with HIV: A systematic review

American Journal of Drug and Alcohol Abuse

Volumn 41, Issue 6, 2015, Pages 479-488

  Kelso, Natalie E ^a   Sheps, David S ^a   Cook, Robert L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alcohol; cardiovascular disease; HIV infection; review; risk factors

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; EFFECT SIZE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION RETRIEVAL; ISCHEMIC HEART DISEASE; MEASUREMENT; MEDLINE; OUTCOME ASSESSMENT; PEER REVIEW; PREVALENCE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; COMPLICATION; DRINKING BEHAVIOR; HIV INFECTIONS; RISK FACTOR;

ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; HIV INFECTIONS; HUMANS; PREVALENCE; RISK FACTORS;

EID: 84944278645     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2015.1058812     Document Type: Review

References (61)

1. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, Vaeth M, Obel N. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146: 87-95
2. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD.; HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34
3. Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, Paredes R, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS 2013; 27: 973-979
4. Centers for Disease Control and Prevention (CDC). National Vital Statistics System: deaths, percent of total deaths, and death rates for 15 leading causes of death: United States and each state, 1999-2013 Available from: http://www.cdc.gov/nchs/data/dvs/LCWK9-2013.pdf [last accessed 6 Sept 2013]
5. DAgostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753
6. Friis-Moller N, Worm SW. Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools? Clin Infect Dis 2007; 45: 1082-1084
7. DAgostino RB Sr. Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population. J Infect Dis 2012; 205: S362-S367
8. Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 2010; 17: 491-501
9. Nery MW, Martelli CM, Silveria EA, de Sousa CA, Falco Mde O, de Castro Ade C, Esper JT, et al. Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons. Scientific World J 2013; 2013: 969281
10. McElduff P, Dobson AJ. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ 1997; 314: 1159-1164
11. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281: 53-60
12. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000; 95: 1505-1523
13. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willett WC, Rimm EB. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348: 109-118
14. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003; 289: 579-588
15. Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction 2012; 107: 1246-1260
16. Roerecke M, Rehm J. Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart 2014; 1: e000135
17. Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014; 64: 281-289
18. Huang C, Zhan J, Liu YJ, Li DJ, Wang SQ, He QQ. Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies. Mayo Clin Proc 2014; 89: 1201-1210
19. Galvan FH, Bing EG, Fleishman JA, London AS, Caetano R, Burnam MA, Longshore D, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol 2002; 63: 179-186
20. Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med 2001; 16: 83-88
21. Conigliaro J, Gordon AJ, McGinnis KA, Rabeneck L, Justice AC.; Veterans Aging Cohort 3-Site Study. How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr 2003; 33: 521-525
22. Hadigan C, Jeste S, Anderson EJ, Tsay R, Cyr H, Grinspoon S. Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution. Clin Infect Dis 2001; 33: 710-717
23. Miguez-Burbano MJ, Lewis JE, Malow R. Alcohol and race/ethnicity elicit different changes in lipid profiles in HIV-infected individuals receiving highly active antiretroviral therapy. J Assoc Nurses AIDS Care 2009; 20: 176-183
24. Hejazi N, Rajikan R, Choong CL, Sahar S. Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. BMC Public Health 2013; 13: 758
25. Justice AC, Lasky E, McGinnis KA, Skanderson M, Conigliaro J, Fultz SL, Crothers K, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care 2006; 44: S52-S60
26. Cook RL, Zhu F, Belnap BH, Weber KM, Cole SR, Vlahov D, Cook JA, et al. Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behavior 2013; 17: 1705-1712
27. Sullivan LE, Goulet JL, Justice AC, Fiellin DA. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend 2011; 117: 158-163
28. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695
29. Strategies for Management of Antiretroviral Therapy Study G., El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2283-2296
30. Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, Martin JN, Deeks SG. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 2009; 23: 1059-1067
31. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201: 1788-1795
32. Rajasuriar R, Khoury G, Kamarulzaman A, French MA, Cameron PU, Lewin SR. Persistent immune activation in chronic HIV infection: do any interventions work? AIDS 2013; 27: 1199-1208
33. Miguez MJ, Rosenberg R, Burbano-Levy X, Carmona T, Malow R. The effect of alcohol use on IL-6 responses across different racial/ethnic groups. Future Virol 2012; 7: 205-213
34. Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013; 21: 6-13
35. Freiberg MS, Kraemer KL. Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease. Alcohol Res Health 2010; 33: 237-246
36. Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012; 30: 149-173
37. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173: 614-622
38. Carrieri MP, Protopopescu C, Le Moing V, Reboud P, Raffi F, Mahy S, Roux P, et al. Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy. BMJ Open 2012; 2: 1-11
39. Freiberg MS, McGinnis KA, Kraemer K, Samet JH, Conigliaro J, Curtis Ellison R, Bryant K, et al. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr 2010; 53: 247-253
40. Belloso WH, Orellana LC, Grinsztejn B, Madero JS, La Rosa A, Veloso VG, Sanchez J, et al. Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites. HIV Med 2010; 11: 554-564
41. Corral I, Quereda C, Moreno A, Pérez-Elías MJ, Dronda F, Casado JL, Muriel A, et al. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovasc Dis 2009; 27: 559-563
42. Durand M, Sheehy O, Baril JG, Lelorier J, Tremblay CL. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Quebecs public health insurance database. J Acquir Immune Defic Syndr 2011; 57: 245-253
43. Durand M, Sheehy O, Baril JG, LeLorier J, Tremblay CL. Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study. J Stroke Cerebrovasc Dis 2013; 22: e34-e41
44. Justice AC, Zingmond DS, Gordon KS, Fultz SL, Goulet JL, King JT Jr, Bravata DM, et al. Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage? Clin Infect Dis 2008; 47: 1226-1230
45. Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, Wood K, et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 2010; 51: 435-447
46. Longo-Mbenza B, Longokolo Mashi M, Lelo Tshikwela M, Mokondjimobe E, Gombet T, Ellenga-Mbolla B, Nge Okwe A, et al. Relationship between younger age, autoimmunity, cardiometabolic risk, oxidative stress, HAART, and ischemic stroke in Africans with HIV/AIDS. ISRN Cardiol 2011; 2011: 897908
47. Orlando G, Guaraldi G, Zona S, Carli F, Bagni P, Menozzi M, Cocchi S, et al. Ectopic fat is linked to prior cardiovascular events in men with HIV. J Acquir Immune Defic Syndr 2012; 59: 494-497
48. Roy VP, Prabhakar S, Pulvirenti J, Mathew J. Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital. J Natl Med Assoc 1999; 91: 502-504
49. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 2007; 5: 129-137
50. Zirpoli JC, Lacerda HR, Albuquerque VM, Albuquerque Mde F, Miranda Filho Dde B, Monteiro VS, de Barros IL, et al. Angina pectoris in patients with HIV/AIDS: prevalence and risk factors. Braz J Infect Dis 2012; 16: 1-8
51. Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ 1968; 56: 1-188
52. Quach S, Blais C, Quan H. Administrative data have high variation in validity for recording heart failure. Can J Cardiol 2010; 26: 306-312
53. Jones SA, Gottesman RF, Shahar E, Wruck L, Rosamond WD. Validity of hospital discharge diagnosis codes for stroke: the Atherosclerosis Risk in Communities Study. Stroke 2014; 45: 3219-3225
54. Thigpen JL, Dillon C, Forster KB, Henault L, Quinn EK, Tripodis Y, Berger PB, et al. Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation. Circ Cardiovasc Qual Outcomes 2015; 8: 8-14
55. Lipsey MW, Wilson DB. Practical meta-analysis: applied social research methods series. Vol. 49. Thousand Oaks, CA: Sage Publications; 1999
56. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993; 88: 791-804
57. Bavinger C, Bendavid E, Neihaus K, Olshen RA, Olkin I, Sundaram V, Wein N, et al. Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review. PloS One 2013; 8: e59551
58. Bloomfield GS, Khazanie P, Morris A, Rabadán-Diehl C, Benjamin LA, Murdoch D, Radcliff VS, et al. HIV and Noncommunicable cardiovascular and pulmonary diseases in low-and middle-income countries in the ART era: what we know and best directions for future research. J Acquir Immune Defic Syndr 2014; 67: S40-S53
59. Torrente MP, Freeman WM, Vrana KE. Protein biomarkers of alcohol abuse. Expert Rev Proteomics 2012; 9: 425-436
60. Hahn JA, Dobkin LM, Mayanja B, Emenyonu NI, Kigozi IM, Shiboski S, Bangsberg DR, et al. Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV positives in sub-Saharan Africa. Alcohol Clin Exp Res 2012; 36: 854-862
61. Hahn JA, Fatch R, Kabami J, Mayanja B, Emenyonu NI, Martin J, Bangsberg DR. Self-report of alcohol use increases when specimens for alcohol biomarkers are collected in persons with HIV in Uganda. J Acquir Immune Defic Syndr 2012; 61: 363-e364